Osaic Holdings
CUE icon

Osaic Holdings’s Cue Biopharma CUE Stock Holding History

Osaic Holdings’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.7K Buy
1,048
+1,000
+2,083% +$29.7K ﹤0.01% 5957
2026
Q2 		$1.51K Buy
48
+38
+380% +$859 ﹤0.01% 7356
2026
Q1 		$69 Sell
10
-13
-57% -$121 ﹤0.01% 7658
2025
Q4 		$209 Hold
23
– – ﹤0.01% 7574
2025
Q3 		$512 Hold
23
– – ﹤0.01% 7547
2025
Q2 		$463 Hold
23
– – ﹤0.01% 7364
2025
Q1 		$618 Buy
23
+10
+77% +$371 ﹤0.01% 6949
2024
Q4 		$414 Hold
13
– – ﹤0.01% 7059
2024
Q3 		$288 Hold
13
– – ﹤0.01% 7113
2024
Q2 		$471 Hold
13
– – ﹤0.01% 6999
2024
Q1 		$718 Buy
13
+11
+550% +$776 ﹤0.01% 6750
2023
Q4 		$164 Hold
2
– – ﹤0.01% 7065
2023
Q3 		$143 Hold
2
– – ﹤0.01% 7191
2023
Q2 		$273 Hold
2
– – ﹤0.01% 7156
2023
Q1 		$202 Sell
2
-67
-97% -$6.39K ﹤0.01% 7266
2022
Q4 		$6K Sell
69
-1,540
-96% -$141K ﹤0.01% 6185
2022
Q3 		$107K Buy
1,609
+317
+25% +$27.3K ﹤0.01% 4305
2022
Q2 		$96K Buy
1,292
+19
+1% +$2.22K ﹤0.01% 4454
2022
Q1 		$2.41M Buy
1,273
+386
+44% +$81.8K ﹤0.01% 1781
2021
Q4 		$301K Sell
887
-154
-15% -$59.6K ﹤0.01% 3562
2021
Q3 		$455K Buy
1,041
+360
+53% +$126K ﹤0.01% 3122
2021
Q2 		$237K Buy
681
+134
+24% +$51.9K ﹤0.01% 3724
2021
Q1 		$200K Buy
547
+543
+13,575% +$223K ﹤0.01% 3733
2020
Q4 		$2K Hold
4
– – ﹤0.01% 6047
2020
Q3 		$2K Hold
4
– – ﹤0.01% 5833
2020
Q2 		$3K Hold
4
– – ﹤0.01% 5646
2020
Q1 		$2K Buy
+4
New +$1.94K ﹤0.01% 5657

Other funds holding CUE

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Aster Capital Management
Aster Capital Management Dubai, United Arab Emirates $275M AUM 18.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Osaic Holdings's CUE Position: Q3 2026 in Review

Osaic Holdings increased its Cue Biopharma (CUE) stake by 2,083% in Q3 2026, buying an estimated $29.7K and bringing the position to 1,048 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5957.

Osaic Holdings first reported a position in CUE in Q1 2020 and has held it in 27 quarters since. The position peaked at $2.41M in Q1 2022. 22 funds tracked by Wall St. Rank hold CUE as of Q3 2026.

  • Osaic Holdings held 1,048 shares of Cue Biopharma worth $26.7K as of Q3 2026.
  • Osaic Holdings bought 1,000 Cue Biopharma shares in Q3 2026, an estimated $29.7K.
  • Cue Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5957 holding.
  • Osaic Holdings first reported a position in Cue Biopharma in Q1 2020 and has held it in 27 quarters since.
  • Osaic Holdings's Cue Biopharma position peaked at $2.41M in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.